So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...

Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device ...

Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation ...

The FDA has classified a corrective action for Tandem Diabetes Care’s Mobi insulin pumps as a Class I recall, its highest ...